Cancer: A Genetic Disease COPY Flashcards
- what type of mutations in proto-oncogenes give rise to oncogenes?
- what are the three main mechanism of gene alterations that activate oncogenes?
1. gain of function mutations in proto-oncogenes give rise to oncogenes
- mechanisms:
- point mutations: single base change in DNA (e.g. Ras oncogene)
- chromsomal rearrangements: translocation of chr activates oncogene by using regulatory elements from a highly transcribed gene to drive expression of oncogene
- gene amplification (e.g HER2)
how does a point mutation in H-ras result in oncogene activation?
- (ras is a GTPase (converts GTP into GDP)
- normally regulates cell proliferation and survival)
- single nucleotide exchange GGC TO GTC in bladder cancers (glycine -> valine)
- get different isoforms of ras gene resulting in different cancers (see photo)
where is c-myc normally encoded?
where is IgH normally encoded?
explain cancer that occurs when the above translocate
- c-myc:* found on chr 8
- on chromsome 14, there is a gene that codes of IgH - has a very strong promoter
- translocation of region of chr 8 and 14: myc gets translocated near to promoter of IgH
- results in strong promoter driving the expression of myc: Burkitt lymphoma
what are the disease characterisitics of Burkitt lymphoma?
disease involves jaw, distal ileum, cecum, ovaries kidney or breast
explain another translocation that occurs with chromsome 14 IgH promoter
- strong promoter of IgH on chromosome translocates to chromsome 18
- switches ON bcl-2 gene (anti-apoptotic protein) in active B-lymphocytes (is normally switched off)
- cells that harbour mutations do not go into apoptosis
- causes lymphoma
which cancers do we see activated bcl-2 being upregulated in?
- leukaemia
- Non-Hodgkin lymphoma
- solid tumours
whats an example of gene amplification of oncogene?
overexpression of HER-2 _(_growth factor receptor) in breast cancer cells
what type of mutations inactivate tumour suppressor genes?
what does a mutation in p53 cause? - how often seen in cancer?
- Loss of function mutations inactivate tumour suppressor genes. often point mutations or small deletions.
- (sometimes somatic recombination during normal gene copy is replaced with mutant copy)
- mutation in p53 causes in cell cycle carrying on and not to stop in G1 (DNA repair) to occur. REPORTED IN NEARLY EVERY TYPE OF CANCER - just different rates
how does p53 mutation often occur?
- point mutations - results in missense mutation - change in sequence in protein doesnt allow it conduct normal function
- majority of mutations result in loss of function of p53’s ability to bind to DNA in a sequence specific manner and activate transcription of p53 target genes
describe how DNA methylation can lead to tumour suppression (epigenetics)
- in promoter AND downstream regions
promoter region:
- mutated tumour suppressor genes often undergo hypermethylation in promoter region (where the CpG island is).
- methylation moves from lysine 4 of the histone 3 (H3) (normal function) to lysine 9 of H3
- leads to transcriptional repression
- loss of tumour suppressor gene expression
Downstream of gene:
- repeat sequences undego hypomethylation
- leads to mitotic recombination and genomic instability.
what does difference in DNMT3B (DNMT3B - DNA methyltransferase 3 Beta) expression show in colon carcinomas?
- how can we use methlylation regions of promoter regions to predict cancer?
- normal -> v aggressive colon carcinoma: little expression of DNMT3B to intense expression of DNMT3B in nuclei
(DNMT3B - DNA methyltransferase 3 Beta)
- increased promoter methylation correlates with grade and stage of cancers
what is penetrance?
which classses of genes may be inherited mutations?
penetrance: the proportion of individuals carrying a pathogenic variant who will manifest the disease
- oncogenes
- tumour suppressor genes
- DNA repair
- cell cycle control
how does inheritance of germ line mutations APC and BRAC1 / 2 influence survival compared to those who are havent inherinted these genes?
(i think more for awareness)
what is Knudson’s two hit hypothesis?
- suggested susceptibility - multiple hits necessary to cause cancer
- a mutation in both alleles of tumour suppressor gene is required in order for malignancy to occur. a single functional tumour suppressor gene is usually sufficient for normal function
- sporadic cancer: needs two acquired mutations. tumour occurs at later age
- hereditary cancer: inherit one mutation and only need one hit to have both hits. tumour occurs earlier age